98%
921
2 minutes
20
Signaling via the receptor of advanced glycation end products (RAGE)-though complex and not fully elucidated in the setting of diabetes-is considered a key injurious pathway in the development of diabetic nephropathy (DN). We report here that RAGE deletion resulted in increased expression of fibrotic markers (collagen I and IV, fibronectin) and the inflammatory marker MCP-1 in primary mouse mesangial cells (MCs) and in kidney cortex. RNA sequencing analysis in MCs from RAGE and wild-type mice confirmed these observations. Nevertheless, despite these gene expression changes, decreased responsiveness to transforming growth factor-β was identified in RAGE mice. Furthermore, RAGE deletion conferred a more proliferative phenotype in MCs and reduced susceptibility to staurosporine-induced apoptosis. RAGE restoration experiments in RAGE MCs largely reversed these gene expression changes, resulting in reduced expression of fibrotic and inflammatory markers. This study highlights that protection against DN in RAGE knockout mice is likely to be due in part to the decreased responsiveness to growth factor stimulation and an antiapoptotic phenotype in MCs. Furthermore, it extends our understanding of the role of RAGE in the progression of DN, as RAGE seems to play a key role in modulating the sensitivity of the kidney to injurious stimuli such as prosclerotic cytokines.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.2337/db17-0538 | DOI Listing |
Metabolites
August 2025
Department of Cell Biology and Physiology, Brigham Young University, Provo, UT 84602, USA.
The receptor for advanced glycation end products (RAGEs) has been implicated in obesity and metabolic dysfunction. However, its precise role in diet-induced obesity remains unclear. In this study, we investigated the metabolic consequences of RAGE knockout (RAGE KO) in mice subjected to a Western diet (WD).
View Article and Find Full Text PDFBrain
August 2025
Graduate Program in Pharmacology, Federal University of Santa Maria (UFSM), 97105-900 Santa Maria (RS), Brazil.
Relapsing-remitting multiple sclerosis (RRMS), is characterized by increased oxidative compound production and neuroinflammation, accompanied by neuropathic pain and anxiety. Activation of nicotinamide adenine dinucleotide phosphate oxidase (Nox) generates oxidative stress by-products that induce nociception and anxiety-like behaviors by transient receptor potential ankyrin 1 (TRPA1) activation in the relapsing-remitting experimental autoimmune encephalomyelitis (RR-EAE) model. Nox activation stimulates myeloperoxidase (MPO), producing advanced oxidation protein products (AOPPs).
View Article and Find Full Text PDFMechanobiol Med
September 2025
Department of Orthopedic Surgery, Washington University School of Medicine, St Louis, MO, USA.
Individuals with type 2 diabetes (T2D) are prone to fracture at numerous skeletal sites despite presenting with a higher bone mineral density (BMD). The accumulation of Advanced Glycation End-products (AGEs) in the bone tissues of patients with T2D could be contributing to this paradox of increased skeletal fragility with higher BMD. AGEs can also impair bone cell homeostasis via the receptor for AGEs (RAGE).
View Article and Find Full Text PDFRedox Biol
July 2025
Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, China; Hubei Key Laboratory of Cardiology, Wuhan, China; Cardiovascular Research Institute of Wuhan University, Wuhan, China. Electronic address:
Background: Diabetic cardiomyopathy (DCM) is a prevalent and severe complication of diabetes, for which effective management strategies remain limited. Ubiquitin-specific protease 38 (USP38) has been associated with various cardiovascular diseases. In this study, we investigate the role of USP38 in the pathogenesis of DCM.
View Article and Find Full Text PDFEBioMedicine
May 2025
Department of Immunology, School of Translational Medicine, Monash University, Melbourne, Victoria, 3004, Australia. Electronic address:
Background: Chronic obstructive pulmonary disease (COPD) is a heterogeneous inflammatory lung disease leading to progressive, destructive lung function decline, disability and death, and it is refractory to all current treatments. Haematopoietic cell kinase (HCK) is a druggable SRC-family non-receptor protein tyrosine kinase and COPD candidate gene. It is implicated in the chronic and non-resolving inflammation that causes mucosecretory bronchitis and destruction of small airways and alveoli, but how it drives pathophysiology remains obscure.
View Article and Find Full Text PDF